Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ASCC1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | TCP11L1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | MYBPC3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | IFNA8 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | PICK1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | SLC47A1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | DENND5A | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | ANO3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | CHURC1-FNTB | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |